Get started
Author

Markus Cybulla

Effect of Ibandronate on Bone Loss and Renal Function after Kidney Transplantation
2001 · WOLFGANG GROTZ, CHRISTIAN NAGEL, et al. · Journal of the American Society of Nephrology · 189
End-stage renal disease after treatment with 90 Y-DOTATOC
2001 · Markus Cybulla, Stefan Weiner, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 154
Dysregulated Autophagy Contributes to Podocyte Damage in Fabry’s Disease
2013 · Max C. Liebau, Fabian Braun, et al. · PLoS ONE · 126
PDF
Alu-Alurecombination underlies the vast majority of largeVHLgermline deletions: Molecular characterization and genotype-phenotype correlations in VHL patients
2009 · Gerlind Franke, Birke Bausch, et al. · Human Mutation · 116
PDF
Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany
2013 · Hartmut P.H. Neumann, Cordula Jilg, et al. · Nephrology Dialysis Transplantation · 104
Renal Toxicity after Radionuclide Therapy
2004 · Bieke Lambert, Markus Cybulla, et al. · Radiation Research · 92
Dose-Dependent Effect of Enzyme Replacement Therapy on Neutralizing Antidrug Antibody Titers and Clinical Outcome in Patients with Fabry Disease
2018 · Malte Lenders, Leon Paul Neußer, et al. · Journal of the American Society of Nephrology · 76
The Effectiveness of Long-Term Agalsidase Alfa Therapy in the Treatment of Fabry Nephropathy
2012 · Sandro Feriozzi, Joan Torras, et al. · Clinical Journal of the American Society of Nephrology · 75
Treatment of Fabry's Disease With Migalastat: Outcome From a Prospective Observational Multicenter Study (FAMOUS)
2020 · Malte Lenders, Peter Nordbeck, et al. · Clinical Pharmacology & Therapeutics · 70
Agalsidase Alfa Slows the Decline in Renal Function in Patients with Fabry Disease
2008 · Sandro Feriozzi, Andreas Schwarting, et al. · American Journal of Nephrology · 68
Treatment of Fabry Disease management with migalastat—outcome from a prospective 24 months observational multicenter study (FAMOUS)
2021 · Malte Lenders, Peter Nordbeck, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 62
Monitoring of renal function in cancer patients: an ongoing challenge for clinical practice
2007 · M. Kleber, M. Cybulla, et al. · Annals of Oncology · 54
Kidney transplantation in patients with Fabry disease
2009 · Markus Cybulla, Kerstin Nanette Walter, et al. · Transplant International · 41
Defective lysosomal storage in Fabry disease modifies mitochondrial structure, metabolism and turnover in renal epithelial cells
2021 · Anke Schumann, Kristin Schaller, et al. · Journal of Inherited Metabolic Disease · 31
PDF
Physical mapping of the gene for juvenile nephronophthisis (NPH1) by construction of a complete YAC contig of 7 Mb on chromosome 2q13
2008 · F. Hildebrandt, M. Cybulla, et al. · Cytogenetics and Cell Genetics · 29
Is radiation nephropathy caused by yttrium-90?
2002 · Andreas Otte, Stefan M Weiner, et al. · The Lancet · 28
Patient reported quality of life and medication adherence in Fabry disease patients treated with migalastat: A prospective, multicenter study
2022 · Jonas Müntze, Kolja Lau, et al. · Molecular Genetics and Metabolism · 26
Chronic Renal Failure and Proteinuria in Adulthood: Fabry Disease Predominantly Affecting the Kidneys
2005 · Markus Cybulla, Ellen Schaefer, et al. · American Journal of Kidney Diseases · 22
Glomerulopathy associated with predominant fibronectin deposits: Exclusion of the genes for fibronectin, villin and desmin as causative genes
1996 · Friedhelm Hildebrandt, Brigitte Strahm, et al. · American Journal of Medical Genetics · 21
Kidney transplantation and enzyme replacement therapy in patients with Fabry disease
2012 · Markus Cybulla, Christine Kurschat, et al. · Journal of Nephrology · 20
New genetic causes of pheochromocytoma: current concepts and the clinical relevance
2005 · Hartmut P.H. Neumann, Markus Cybulla, et al. · The Keio Journal of Medicine · 20
PDF
Adult patients with sporadic polycystic kidney disease: the importance of screening for mutations in the PKD1 and PKD2 genes
2012 · Hartmut P. H. Neumann, Janina Bacher, et al. · International Urology and Nephrology · 18
Genetic and Clinical Investigation of Pheochromocytoma
2006 · BIRKE BAUSCH, CARSTEN C. BOEDEKER, et al. · Annals of the New York Academy of Sciences · 16
Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry Disease
2022 · Markus Cybulla, Kathleen Nicholls, et al. · Journal of Clinical Medicine · 13
PDF
90 Y-DOTATOC and nephrotoxicity
2002 · Andreas Otte, Markus Cybulla, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 13
Works count: 74
Citation count: 1,565
H-index: 20
I10-index: 28
Year
Topic
Type